首页 > 市场调查报告书 > 医疗设备

生物材料

市场调查报告书

商品编码

1534944

骨腔填充物市场:现状分析与预测(2024-2032年)

Bone Void Fillers Market: Current Analysis and Forecast (2024-2032)

出版日期: 2024年07月01日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 138 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录

骨腔填充剂是一种医疗设备，旨在解决因受伤、疾病或手术造成的缺陷，并为患者康復提供合适的介质。这些材料能够透过为受影响区域提供支撑、骨骼癒合和功能支持来增强骨骼结构。生物活性材料取自陶瓷、磷酸钙、硅酸盐生物玻璃、聚合物和胶原蛋白等天然产物。骨折、骨质疏鬆症和关节炎等骨科疾病的盛行率不断上升，大大增加了对骨腔填充剂的需求。随着世界人口老化，需要手术介入的肌肉骨骼损伤和疾病正在增加。根据 NHS 估计，到 2022 年，75 岁以上的人中约有 69% 患有肌肉骨骼疾病，而 25 岁至 44 岁的人中这一比例为 23%。女性罹患骨质疏鬆症的可能性是男性的 5 倍，关节炎的可能性是男性的 1.4 倍。

在预测期（2024-2032 年），骨腔填充剂市场预计将以 6.8% 的复合年增长率大幅增长。这是由于对研发的持续投资，这对于开发更俱生物相容性、耐用性和有效促进骨癒合的创新骨腔填充剂至关重要。这包括探索新的生物材料，例如模仿天然骨骼特性的合成聚合物和生物陶瓷。 2021 年 9 月，专注于脊椎和骨科的全球医疗器械公司 Orthofix Medical Inc. 宣布推出 Opus Mg Set 骨传导支架，这是一种用于骨科手术的合成镁基骨空隙填充物。

依类型划分，市场分为去矿骨、胶原蛋白基质、硫酸钙基质和磷酸三钙。 2023年，脱钙骨将占据压倒性的市场。这主要是由于其独特的生物学特性和多功能的骨科和脊椎外科应用。随着对微创手术和生物相容性材料的需求不断增加，脱矿骨仍然是不断扩大的骨腔填充剂市场的基石。例如，2022 年10 月，Orthofix Medical Inc. 宣布全面上市Legacy 脱矿骨基质(DBM)，这是一种用于填充脊柱、骨盆和四肢骨缺损和创伤中的空隙和间隙的油灰，以及第一个植入物宣布。此外，外科医生更喜欢脱矿骨，因为它具有骨传导和骨诱导特性，可以提供结构支撑并刺激新骨生长。

依形式，市场分为凝胶颗粒、膏状腻子等。预计在预测期内（2024-2032 年）凝胶颗粒将以显着的复合年增长率成长。这些颗粒含有透明质酸和合成聚合物，天然类似骨头的细胞外基质。这些支持细胞附着和生长，同时具有针对复杂骨缺损的水凝胶特性。随着生物材料的进步，凝胶颗粒的新商机有望出现。申请人正在评估其适应骨科和重建手术中骨修復患者要求的能力。

根据最终用户，市场分为医院、专科诊所等。到2023年，医院将占据压倒性的市场占有率。骨质疏鬆症、骨折综合症和其他骨科疾病也变得越来越常见，需要有效的治疗，例如填补骨缺损。例如，在美国(NHIS)，2019 年至2021 年，约5.4% 的18 至44 岁成年人报告患有关节炎，四分之一(26.0%) 的45 至64 岁成年人报告患有医生诊断的关节炎。此外，医院对于新技术和填充材料的临床研究、评估其有效性并识别可能的不良反应至关重要。手术中先进仪器的使用和对病患治疗结果的重视也是推动市场扩张的因素。

为了更了解骨腔填充剂的市场介绍，将市场分为北美（美国、加拿大等北美地区）、欧洲（德国、法国、英国、西班牙、义大利等欧洲地区）地区）、亚太地区（中国根据世界其他地区（日本、印度、亚太其他地区）和世界其他地区的全球影响力进行分析。亚太地区预计在预测期（2024-2032 年）将以显着的复合年增长率成长。该地区正在经历快速的经济成长，随着关节炎和其他骨科问题患者接受先进医疗程序的入院人数的增加，医疗保健领域的支出持续增加。亚太国家的人口老化正在引发骨质疏鬆、骨折和退化性关节炎等骨科问题。此外，3D 列印植入物和可生物降解的神经解剖填充物等技术正在成为服务领域的新兴趋势，因为它们与人体解剖结构精确匹配，术后感染的可能性较小。

市场上营运的主要公司包括 Stryker、Medical Device Business Services, Inc.（强生）、Medtronic、Zimmer Biomet、Smith+Nephew、Globus Medical、Orthofix Medical Inc.、Baxter Arthrex, Inc.、SeaSpine、 ETC。

Bone void fillers are medical devices designed to provide an appropriate medium for patient recovery by addressing defects as a result of injury, illness, or surgery. These materials offer capacity, which is enhanced by offering support for the skeletal structures, healing of the bones as well as the provision of functional support for the affected area. The bioactive materials can be derived from ceramics, calcium phosphate, silicate bioglasses, polymers, and natural products such as collagen. The rising prevalence of orthopedic disorders, such as fractures, osteoporosis, and arthritis, contributes significantly to the demand for bone void fillers. As the global population ages, there is an increase in musculoskeletal injuries and diseases that require surgical intervention. According to the NHS, in 2022, around 69% of people aged 75 and over were estimated to be living with a musculoskeletal condition, compared with 23% of people aged 25-44. females, compared with males, were 5 times as likely to be living with osteoporosis and 1.4 times as likely to be living with arthritis.

The Bone Void Fillers Market is expected to grow with a significant CAGR of 6.8% during the forecast period (2024-2032). This can be attributed to the continued investment in research and development, which is crucial to developing innovative bone void fillers that enhance biocompatibility, durability, and effectiveness in promoting bone healing. This includes exploring new biomaterials, such as synthetic polymers and bioceramics, that mimic natural bone properties. In September 2021, Orthofix Medical Inc., a global medical device company with a spine and orthopedics focus, announced the full market launch of the Opus Mg Set osteoconductive scaffold, a synthetic magnesium-based bone void filler for orthopedic procedures.

Based on the type, the market has been divided into demineralized bone, collagen matrix, matrix calcium sulfate, and tri-calcium phosphate. The demineralized bone held a dominant market share in 2023. This is mainly due to its unique biological properties and versatile orthopedic and spinal surgery applications. As demand for minimally invasive procedures and biocompatible materials grows, demineralized bone remains a cornerstone in the expanding bone void fillers market. For instance, in October 2022, Orthofix Medical Inc. announced the full market release and first implants of Legacy Demineralized Bone Matrix (DBM), a putty for filling voids or gaps in bony defects or traumatic injuries of the spine, pelvis, or extremities. Moreover, surgeons prefer demineralized bone due to its osteoconductive and osteoinductive properties, which provide structural support and stimulate new bone growth.

Based on the form, the market is segmented into gel granules, paste putty, and others. The gel granules are expected to grow with a significant CAGR in the forecast period (2024-2032). These granules include ongoing hyaluronic acid or synthetic polymers that naturally resemble the bone extracellular matrix. They support cell attachment and growth while at the same time are hydrogel in nature to assume complex bone defects. New opportunities for gel granules are anticipated to emerge as biomaterials advance; applicants value their ability to adapt to patient's requirements in regard to bone restoration during orthopedic and reconstructive operations.

Based on the end-user, the market is segmented into hospitals, specialty clinics, and others. Hospitals held a dominant share of the market in 2023. Osteoporosis, fracture syndromes, and other orthopedic diseases also become more frequent, requiring effective remedies for their treatment, for example, the filling of bone defects. For instance, from 2019 to 2021 in the United States (NHIS), around 5.4% of adults 18 to 44 years old reported arthritis, and Among adults aged 45 to 64 years, one-in-four (26.0%) reported doctor-diagnosed arthritis. Moreover, hospitals are essential players in the clinical research of new technologies and materials for fillers, assessments of their effectiveness, and identification of possible negative consequences. The use of sophisticated instruments in surgeries and their focus on patients' outcomes are other factors that will help expand the market.

For a better understanding of the market adoption of bone void fillers, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, France, U.K., Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. Asia-Pacific is expected to grow with a significant CAGR in the forecast period (2024-2032). The region is experiencing rapid economic growth, and the healthcare sector expenditures continue to rise with improved admission to sophisticated medical procedures for patients with diseases such as arthritis and other orthopedic problems. An older population base in Asia-Pacific countries results in an emerging concern of orthopedics, which comprises osteoporosis, bone fractures, and degenerative arthritis. Furthermore, techniques like 3D printed implants and biodegradable neuroanatomy fillings are emerging trends for the services as they provide the exact fit of the human anatomy and give less chance of post-surgery infection.

Some of the major players operating in the market include Stryker, Medical Device Business Services, Inc. (Johnson & Johnson), Medtronic, Zimmer Biomet, Smith+Nephew, Globus Medical, Orthofix Medical Inc., Baxter Arthrex, Inc., SeaSpine.

1.MARKET INTRODUCTION

1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation

2.RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Process of the Bone Void Fillers Market
2.2. Research Methodology of the Bone Void Fillers Market
2.3. Respondent Profile

3.EXECUTIVE SUMMARY

3.1. Industry Synopsis
3.2. Segmental Outlook
- 3.2.1. Market Growth Intensity
3.3. Regional Outlook

4.MARKET DYNAMICS

4.1. Drivers
4.2. Opportunity
4.3. Restraints
4.4. Trends
4.5. PESTEL Analysis
4.6. Demand Side Analysis
4.7. Supply Side Analysis
- 4.7.1. Merger & Acquisition
- 4.7.2. Investment Scenario
- 4.7.3. Industry Insights: Leading Startups and Their Unique Strategies

5.PRICING ANALYSIS

5.1. Regional Pricing Analysis
5.2. Price Influencing Factors

6.GLOBAL BONE VOID FILLERS MARKET REVENUE (USD BN), 2022-2032F

7.MARKET INSIGHTS BY TYPE

7.1. Demineralized Bone
7.2. Collagen Matrix
7.3. Matrix Calcium Sulfate
7.4. Tri-Calcium Phosphate
7.5. Others

8.MARKET INSIGHTS BY FORM

8.1. Gel Granules
8.2. Paste Putty
8.3. Others

9.MARKET INSIGHTS BY END-USER

9.1. Hospitals
9.2. Specialty Clinics
9.3. Others

10.MARKET INSIGHTS BY REGION

10.1. North America
- 10.1.1. U.S.
- 10.1.2. Canada
- 10.1.3. Rest of North America
10.2. Europe
- 10.2.1. Germany
- 10.2.2. France
- 10.2.3. UK
- 10.2.4. Spain
- 10.2.5. Italy
- 10.2.6. Rest of Europe
10.3. Asia-Pacific
- 10.3.1. China
- 10.3.2. Japan
- 10.3.3. India
- 10.3.4. Rest of APAC
10.4. Rest of the World

11.VALUE CHAIN ANALYSIS

11.1. Marginal Analysis
11.2. List of Market Participants

12.COMPETITIVE LANDSCAPE

12.1. Competition Dashboard
12.2. Competitor Market Positioning Analysis
12.3. Porter Five Forces Analysis

13.COMPANY PROFILES

13.1. Stryker
- 13.1.1. Company Overview
- 13.1.2. Key Financials
- 13.1.3. SWOT Analysis
- 13.1.4. Product Portfolio
- 13.1.5. Recent Developments
13.2. Medical Device Business Services, Inc. (Johnson & Johnson)
13.3. Medtronic
13.4. Zimmer Biomet
13.5. Smith+Nephew
13.6. Globus Medical
13.7. Orthofix Medical Inc.
13.8. Baxter
13.9. Arthrex, Inc.
13.10. SeaSpine

14.ACRONYMS & ASSUMPTION

15.ANNEXURE

02-2729-4219

+886-2-2729-4219

License/价格

骨腔填充物市场:现状分析与预测(2024-2032年)

Bone Void Fillers Market: Current Analysis and Forecast (2024-2032)

目录

第1章市场简介

第2章调查手法或前提条件

第3章摘要整理

第4章市场动态

第5章价格分析

第6章全球骨腔填充物市场收益，2022-2032年

第7章各类型的市场分析

第8章不同形态的市场分析

第9章各终端用户的市场分析

第10章各地区的市场分析

第11章价值链分析

第12章竞争情形

第13章企业简介

第14章缩写与前提条件

第15章附录